Guided Therapeutics (GTHP) Other financing activities (2011 - 2024)
Guided Therapeutics (GTHP) reported Other financing activities of -$300000.0 for Q4 2024, down 53.85% on a YoY basis from -$650000.0 in Q1 2024, and down 200.0% sequentially from $300000.0 in Q3 2024.
Guided Therapeutics (GTHP) Other financing activities (2011 - 2024) Analysis & Trends
Guided Therapeutics (GTHP) has 9 years of Other financing activities data on file, last reported at -$300000.0 in Q4 2024.
- For the quarter ending Q4 2024, Other financing activities fell 53.85% year-over-year to -$300000.0; the trailing twelve-month figure through Sep 2024 stood at $105000.0 (down 54.74% YoY), and the FY2022 full-year result was $532000.0, changed N/A from the prior year.
- Other financing activities retreated to -$300000.0 in Q4 2024, from $300000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $365000.0 in Q1 2022 to a low of -$300000.0 in Q4 2024.
- A 4-year average of $66888.9 and a median of $67000.0 in 2020 frame the typical range for Other financing activities.
- Peak annual rise in Other financing activities reached 46.58% in 2023, while the deepest fall reached 627.03% in 2023.
- Tracing GTHP's Other financing activities over 4 years: stood at $3000.0 in 2020, then jumped by 1133.33% to $37000.0 in 2022, then sank by 627.03% to -$195000.0 in 2023, then plunged by 53.85% to -$300000.0 in 2024.
- Business Quant data shows GTHP's Other financing activities at -$300000.0 in Q4 2024, $300000.0 in Q3 2024, and -$195000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Guided Therapeutics | 21.96 Mn | 21.89 Mn | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -300,000.00 |
| Dec 31, 2024 | -300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Dec 31, 2023 | -195,000.00 |
| Dec 31, 2023 | -195,000.00 |
| Mar 31, 2023 | 195,000.00 |
| Mar 31, 2023 | 195,000.00 |
| Dec 31, 2022 | 37,000.00 |
| Dec 31, 2022 | 37,000.00 |
| Jun 30, 2022 | 130,000.00 |
| Jun 30, 2022 | 130,000.00 |
| Mar 31, 2022 | 365,000.00 |
| Mar 31, 2022 | 365,000.00 |
| Sep 30, 2020 | 3,000.00 |
| Sep 30, 2020 | 3,000.00 |
| Jun 30, 2020 | 67,000.00 |
| Jun 30, 2020 | 67,000.00 |
| Dec 31, 2015 | 2,000.00 |
| Dec 31, 2015 | 2,000.00 |